PART I Our Company Company Overview Vivani Medical, Inc. (Vivani, the Company, we, us, our or similar terms) is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercia...
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001753926-26-000548 | EDGAR | 84K words |
| 2025-03-31 | 2024-12-31 | 0001753926-25-000527 | EDGAR | — |
| 2024-03-26 | 2023-12-31 | 0001753926-24-000616 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001753926-23-000344 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0001753926-22-000356 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001564590-21-013636 | EDGAR | — |
| 2020-03-19 | 2019-12-31 | 0001564590-20-011809 | EDGAR | — |
| 2019-03-19 | 2018-12-31 | 0001564590-19-008372 | EDGAR | — |
| 2018-03-20 | 2017-12-31 | 0001615774-18-002008 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001615774-17-001057 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001753926-25-001770 | EDGAR | 27K words |
| 2025-08-13 | 2025-06-30 | 0001753926-25-001330 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001753926-25-000794 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001753926-24-001874 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001753926-24-001420 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001753926-24-000959 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001753926-23-001474 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001753926-23-001062 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001753926-23-000655 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001753926-22-001464 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001753926-22-001055 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001753926-22-000721 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001753926-26-000550 | EDGAR | 3K words |
| 2026-01-27 | 0001753926-26-000194 | EDGAR | — |
| 2025-11-13 | 0001753926-25-001768 | EDGAR | — |
| 2025-10-28 | 0001753926-25-001655 | EDGAR | — |
| 2025-10-03 | 0001753926-25-001582 | EDGAR | — |
| 2025-09-17 | 0001753926-25-001510 | EDGAR | — |
| 2025-09-09 | 0001753926-25-001443 | EDGAR | — |
| 2025-09-04 | 0001753926-25-001431 | EDGAR | — |
| 2025-08-13 | 0001753926-25-001328 | EDGAR | — |
| 2025-08-05 | 0001753926-25-001228 | EDGAR | — |
308 total filings indexed. 276 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001266806 |
| Ticker | VANI |
| Exchange | Nasdaq |
| SIC | 3845: Electromedical & Electrotherapeutic Apparatus |
| Incorporated | DE |
| Website | https://www.vivani.com |
| Listed | 2022-08-31 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report